Plain-English translation of NCT06986993 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This is a pilot study testing whether , a medication used to help with weight loss, might also affect smoking behavior and cravings. Half of the 40 participants will receive weekly injections of for 12 weeks, while the other half will receive placebo (inactive) injections. The researchers want to see how the medication impacts tobacco use, nicotine cravings, and the desire to quit smoking.
There is limited research on whether medications that help with weight loss might also help reduce smoking behavior. This study aims to explore that connection and understand the biological changes that might happen, which could lead to new ways to help people quit smoking.
You likely qualify if…
You likely don't qualify if…
You will come in for visits over 12 weeks to receive weekly injections—either the active medication or placebo. You'll also complete surveys on your phone about your smoking cravings and behaviors, wear a glucose monitor to track blood sugar changes, and provide blood samples so researchers can examine biological markers of health. The study combines medical lab work with real-world tracking to understand how the treatment affects both your body and your smoking habits.
AI-generated summary from trial data · Jun 16, 2026 · Not medical advice
United States